Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center, also known historically as Roswell Park Cancer Institute and supported by the Roswell Park Alliance Foundation, is a leading institution dedicated to the fight against cancer. Its core mission is to eliminate cancer through a tripartite approach of innovative research, exceptional patient care, and comprehensive education and training. As a National Cancer Institute-designated comprehensive cancer center, it offers a full continuum of services from cancer prevention and early detection to advanced treatment, survivorship support, and palliative care. The center serves a diverse patient population, drawing individuals from upstate New York, the broader United States, and even international locations seeking specialized oncology expertise. In addition to clinical services, Roswell Park conducts a robust portfolio of basic, translational, and clinical research aimed at discovering new cancer therapies and improving existing ones. Educational initiatives are integral, providing training for physicians, scientists, nurses, and community health workers, as well as public outreach to promote cancer awareness and prevention. The organization operates as a not-for-profit entity, reinvesting all resources into its mission to reduce the burden of cancer.

Founded in 1898 by Dr. Roswell Park, the institution holds the distinction of being the first cancer research center established in the United States, a legacy that continues to shape its pioneering spirit. Today, it is an integral part of the State University of New York (SUNY) system, which provides academic affiliation and access to a wide network of collaborators. The center's clinical enterprise is large and multidisciplinary, encompassing medical oncology, radiation oncology, surgical oncology, and numerous specialty programs. Patients benefit from cutting-edge treatment modalities, including immunotherapy, targeted therapy, genomic medicine, and minimally invasive surgical techniques. Research at Roswell Park is organized around thematic programs such as cancer genetics, tumor microenvironment, cancer prevention and control, and population health disparities, fostering interdisciplinary collaboration. The institution's scientific output is substantial, with faculty regularly publishing in high-impact journals and securing competitive federal grants. Its clinical trials program offers patients access to novel therapies, often before they become widely available, underscoring the center's role as a hub for translational medicine.

Roswell Park's comprehensive designation from the National Cancer Institute is a hallmark of excellence, recognizing its ability to integrate laboratory discoveries with patient-centered care and to disseminate knowledge broadly. A distinguishing feature is its seamless bench-to-bedside pipeline, where basic research findings are rapidly evaluated in clinical settings, accelerating the development of new treatments. The Roswell Park Alliance Foundation, a separate 501(c)(3) nonprofit organization, plays a critical role by raising philanthropic funds to support research initiatives, patient assistance programs, and capital projects. These contributions enable the cancer center to pursue high-risk, high-reward research and to expand access to care for underserved populations. Governance of the overall enterprise is provided by a board of trustees that oversees both the cancer center and the foundation, ensuring strategic alignment with the mission. As a publicly supported institution, Roswell Park is deeply committed to community service, health equity, and the reduction of cancer disparities both regionally and globally. Its long-standing reputation, combined with its ongoing innovations, solidifies its position as a leader in the global fight against cancer.